Genomics Services MarketSize, Share & Industry Analysis, 2026-2034By Service TypeBy Sequencing TechnologyBy ApplicationBy Workflow StageBy End UserBy Sample TypeBy Disease AreaBy Service Provider ModelBy Project ScaleBy Delivery ModelBy Regulatory and Accreditation Status
Full title & scope — all 11 axes with their segments
Genomics Services Market Size, Share & Industry Analysis, By Service Type (Next-Generation Sequencing Services, Sanger Sequencing Services, Microarray Services, Genotyping Services, Epigenomics Services, Bioinformatics and Data Analysis Services, Other Genomics Services), By Sequencing Technology (Short-Read Sequencing, Long-Read Sequencing, Sanger Sequencing, Microarray-Based Platforms, Real-Time PCR and Digital PCR), By Application (Research, Clinical Diagnostics, Drug Discovery and Development, Precision and Personalized Medicine, Agriculture and Animal Genomics, Consumer Genomics), By Workflow Stage (Sample Preparation and Library Construction, Sequencing / Data Generation, Primary and Secondary Analysis, Tertiary Analysis and Interpretation, Reporting and Data Management), By End User (Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Hospitals and Diagnostic Laboratories, Government and Public Health Agencies, Agricultural and Food Companies, Direct-to-Consumer), By Sample Type (Blood, Tissue, Saliva and Buccal Swab, Microbial and Environmental Samples, Plant and Animal Samples, Other Sample Types), By Disease Area (Oncology, Rare and Genetic Disorders, Infectious Diseases, Cardiovascular Diseases, Neurological Disorders, Reproductive Health, Other Disease Areas), By Service Provider Model (Core Facility and Academic Service Labs, Commercial Genomics Service Providers, Instrument Vendor Service Divisions, Clinical Reference Laboratories, Contract Research Organization Genomics Units), By Project Scale (Single-Sample and Small-Batch Projects, Mid-Scale Cohort Studies, Population-Scale and Biobank Programs, Ongoing Routine Testing Volumes), By Delivery Model (Outsourced Service Contracts, Fee-for-Service Per Sample, Subscription and Bundled Analysis Plans, Partnership and Collaborative Programs), By Regulatory and Accreditation Status (Research Use Only, CLIA / CAP Certified Clinical, ISO 15189 Accredited, CE-IVD / FDA-Cleared or Approved Assays), and Regional Forecast, 2026-2034
Segment definitions and share of revenue by product, animal, end user and region.
Segmentation Analysis
11 axesBy Service Type
7- 01Next-Generation Sequencing Services
- 02Sanger Sequencing Services
- 03Microarray Services
- 04Genotyping Services
- 05Epigenomics Services
- 06Bioinformatics and Data Analysis Services
- 07Other Genomics Services
By Sequencing Technology
5- 01Short-Read Sequencing
- 02Long-Read Sequencing
- 03Sanger Sequencing
- 04Microarray-Based Platforms
- 05Real-Time PCR and Digital PCR
By Application
6- 01Research
- 02Clinical Diagnostics
- 03Drug Discovery and Development
- 04Precision and Personalized Medicine
- 05Agriculture and Animal Genomics
- 06Consumer Genomics
By Workflow Stage
5- 01Sample Preparation and Library Construction
- 02Sequencing / Data Generation
- 03Primary and Secondary Analysis
- 04Tertiary Analysis and Interpretation
- 05Reporting and Data Management
By End User
7- 01Academic and Research Institutes
- 02Pharmaceutical and Biotechnology Companies
- 03Contract Research Organizations
- 04Hospitals and Diagnostic Laboratories
- 05Government and Public Health Agencies
- 06Agricultural and Food Companies
- 07Direct-to-Consumer
By Sample Type
6- 01Blood
- 02Tissue
- 03Saliva and Buccal Swab
- 04Microbial and Environmental Samples
- 05Plant and Animal Samples
- 06Other Sample Types
By Disease Area
7- 01Oncology
- 02Rare and Genetic Disorders
- 03Infectious Diseases
- 04Cardiovascular Diseases
- 05Neurological Disorders
- 06Reproductive Health
- 07Other Disease Areas
By Service Provider Model
5- 01Core Facility and Academic Service Labs
- 02Commercial Genomics Service Providers
- 03Instrument Vendor Service Divisions
- 04Clinical Reference Laboratories
- 05Contract Research Organization Genomics Units
By Project Scale
4- 01Single-Sample and Small-Batch Projects
- 02Mid-Scale Cohort Studies
- 03Population-Scale and Biobank Programs
- 04Ongoing Routine Testing Volumes
By Delivery Model
4- 01Outsourced Service Contracts
- 02Fee-for-Service Per Sample
- 03Subscription and Bundled Analysis Plans
- 04Partnership and Collaborative Programs
By Regulatory and Accreditation Status
4- 01Research Use Only
- 02CLIA / CAP Certified Clinical
- 03ISO 15189 Accredited
- 04CE-IVD / FDA-Cleared or Approved Assays
Segment categories shown for scope reference. See the Summary tab for revenue share by Service Type. Full segment-by-segment detail across every axis is available in the sample and full report.
Questions This Report Answers
6 questionsWhat is the market size and growth rate, globally and by region?
How is the market segmented, and which segments lead?
Which regions and countries are covered, and how do they compare?
What are the key drivers, restraints, opportunities and challenges?
Who are the leading companies operating in this market?
What trends are expected to shape the market through the forecast period?
Frequently Asked Questions
01What is the Genomics Services Market projected to reach?
USD 36.6 USD Billion by 2034, CAGR 11.12%
02What years does this report cover?
Study period 2020–2034, base year 2025, historical data 2020-2024, forecast period 2026-2034.
03Which regions are covered?
North America, Europe, Asia Pacific, Latin America, Middle East and Africa.
04Which region accounted for the largest market share?
North America leads with 41% of global revenue through 2034.
05Which segment leads the market?
Next-Generation Sequencing Services is the largest line by service type, at 46% of revenue in 2025.
06Who are the key companies profiled?
Illumina, Inc., Thermo Fisher Scientific Inc., BGI Genomics Co., Ltd., Eurofins Scientific SE, Macrogen, Inc., Psomagen, Inc., Azenta Life Sciences (GENEWIZ), Agilent Technologies, Inc., QIAGEN N.V., Novogene Co., Ltd., Pacific Biosciences of California, Inc., Oxford Nanopore Technologies plc, Element Biosciences, Inc., 10x Genomics, Inc., Revvity, Inc., Charles River Laboratories International, Inc., Fulgent Genetics, Inc., GeneDx Holdings Corp., Invitae Corporation, Laboratory Corporation of America Holdings (Labcorp), Quest Diagnostics Incorporated, Integrated DNA Technologies, Inc., CD Genomics, Genome Quebec / Genome Sciences Centre, Admera Health, LLC, Theragen Bio Co., Ltd., GenScript Biotech Corporation, Personalis, Inc.. Full profiles are part of the paid report.
07Can the segmentation be customized?
Yes. Custom data cuts by geography, segment, or competitor set are available on request.
Why choose CDI
Need this report shaped around your question?
The scope isn't fixed. Tell us what your team needs that the standard edition doesn't cover, and an analyst will come back on what can be adjusted and how long it takes, before you commit to anything.
Most licences include 30–60 hours of customization at no extra cost. See what each licence includes
Additional Companies
Add competitors, suppliers or the peer set you benchmark against to the companies already covered.
Deeper Competitive View
Sharpen the landscape work around your own position: product line, channel, or a named shortlist of rivals.
Extra Segment Splits
Break the market down along an axis the standard scope doesn't cut it by, or go a level deeper inside one.
Application Focus
Narrow the analysis to the specific use cases and end users your team actually sells into.
Different Time Frame
Move the base year, or widen the historical and forecast windows the study is built on.
Country-Level Detail
Go below region level into the individual countries that matter to you, rather than the standard geography split.